Eric Adjei Boakye1, Daphne Lew2, Meera Muthukrishnan3, Betelihem B Tobo3, Rebecca L Rohde4, Mark A Varvares5, Nosayaba Osazuwa-Peters3,6,7. 1. a Saint Louis University Center for Health Outcomes Research (SLUCOR), Saint Louis University , Saint Louis , MO , USA. 2. b Department of Biostatistics , College for Public Health and Social Justice, Saint Louis University , Saint Louis , MO , USA. 3. c Department of Epidemiology , College for Public Health and Social Justice, Saint Louis University , Saint Louis , MO , USA. 4. d Saint Louis University School of Medicine , Saint Louis , MO , USA. 5. e Department of Otolaryngology , The Massachusetts Eye and Ear Infirmary, Harvard Medical School , Boston , MA , USA. 6. f Department of Otolaryngology-Head and Neck Surgery , Saint Louis University , Saint Louis , MO , USA. 7. g Saint Louis University Cancer Center , Saint Louis , MO , USA.
Abstract
PURPOSE: To examine correlates of HPV vaccination uptake in a nationally representative sample of 18-26-year-old adults. METHODS: Young adults aged 18-26 years were identified from the 2014 and 2015 National Health Interview Survey (n = 7588). Survey-weighted multivariable logistic regression models estimated sociodemographic factors associated with HPV vaccine initiation (≥1 dose) and completion (≥3 doses). RESULTS: Approximately 27% of study participants had initiated the HPV vaccine and 16% had completed the HPV vaccine. Participants were less likely to initiate the vaccine if they were men [(adjusted odds ratio) 0.19; (95% confidence interval) 0.16-0.23], had a high school diploma (0.40; 0.31-0.52) or less (0.46; 0.32-0.64) vs. college graduates, and were born outside the United States (0.52; 0.40-0.69). But, participants were more likely to initiate the HPV vaccine if they visited the doctor's office 1-5 times (2.09; 1.56-2.81), or ≥ 6 times (1.86; 1.48-2.34) within the last 12 months vs. no visits. Odds of completing HPV vaccine uptake followed the same pattern as initiation. And after stratifying the study population by gender and foreign-born status, these variables remained statistically significant. CONCLUSIONS: In our nationally representative study, only one out of six 18-26 year olds completed the required vaccine doses. Men, individuals with high school or less education, and those born outside the United States were less likely to initiate and complete the HPV vaccination. Our findings suggest that it may be useful to develop targeted interventions to promote HPV vaccination among those in the catch-up age range.
PURPOSE: To examine correlates of HPV vaccination uptake in a nationally representative sample of 18-26-year-old adults. METHODS: Young adults aged 18-26 years were identified from the 2014 and 2015 National Health Interview Survey (n = 7588). Survey-weighted multivariable logistic regression models estimated sociodemographic factors associated with HPV vaccine initiation (≥1 dose) and completion (≥3 doses). RESULTS: Approximately 27% of study participants had initiated the HPV vaccine and 16% had completed the HPV vaccine. Participants were less likely to initiate the vaccine if they were men [(adjusted odds ratio) 0.19; (95% confidence interval) 0.16-0.23], had a high school diploma (0.40; 0.31-0.52) or less (0.46; 0.32-0.64) vs. college graduates, and were born outside the United States (0.52; 0.40-0.69). But, participants were more likely to initiate the HPV vaccine if they visited the doctor's office 1-5 times (2.09; 1.56-2.81), or ≥ 6 times (1.86; 1.48-2.34) within the last 12 months vs. no visits. Odds of completing HPV vaccine uptake followed the same pattern as initiation. And after stratifying the study population by gender and foreign-born status, these variables remained statistically significant. CONCLUSIONS: In our nationally representative study, only one out of six 18-26 year olds completed the required vaccine doses. Men, individuals with high school or less education, and those born outside the United States were less likely to initiate and complete the HPV vaccination. Our findings suggest that it may be useful to develop targeted interventions to promote HPV vaccination among those in the catch-up age range.
Entities:
Keywords:
18–26 year olds; Foreign-born status; Gender disparities; HPV vaccine; HPV vaccine initiation and completion; Human papillomavirus; NHIS; Young Adults
Authors: Ellen M Daley; Cheryl A Vamos; Gregory D Zimet; Zeev Rosberger; Erika L Thompson; Laura Merrell Journal: Am J Public Health Date: 2016-06 Impact factor: 9.308
Authors: Eric Adjei Boakye; Betelihem B Tobo; Nosayaba Osazuwa-Peters; Kahee A Mohammed; Christian J Geneus; Mario Schootman Journal: Am J Prev Med Date: 2016-11-24 Impact factor: 5.043
Authors: Mona Saraiya; Elizabeth R Unger; Trevor D Thompson; Charles F Lynch; Brenda Y Hernandez; Christopher W Lyu; Martin Steinau; Meg Watson; Edward J Wilkinson; Claudia Hopenhayn; Glenn Copeland; Wendy Cozen; Edward S Peters; Youjie Huang; Maria Sibug Saber; Sean Altekruse; Marc T Goodman Journal: J Natl Cancer Inst Date: 2015-04-29 Impact factor: 13.506
Authors: Alan G Nyitray; Roberto J Carvalho da Silva; Maria Luiza Baggio; Beibei Lu; Danélle Smith; Martha Abrahamsen; Mary Papenfuss; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: J Infect Dis Date: 2011-01-01 Impact factor: 5.226
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Julia López; Vy T Pham; Betelihem B Tobo; Leping Wan; Mario Schootman; Jane A McElroy Journal: Hum Vaccin Immunother Date: 2020-07-23 Impact factor: 3.452
Authors: Lane McLendon; Jesse Puckett; Chelsea Green; Jenna James; Katharine J Head; Hee Yun Lee; Jennifer Young Pierce; Mark Beasley; Casey L Daniel Journal: Hum Vaccin Immunother Date: 2020-12-16 Impact factor: 3.452
Authors: Taylor Rubens-Augustson; Lindsay A Wilson; Malia Sq Murphy; Cindy Jardine; Kevin Pottie; Charles Hui; Martin Stafström; Kumanan Wilson Journal: Hum Vaccin Immunother Date: 2018-11-05 Impact factor: 3.452
Authors: Eric Adjei Boakye; Wenhui Zeng; Samuel Governor; Shreya Nagendra; Betelihem B Tobo; Matthew C Simpson; Nosayaba Osazuwa-Peters Journal: Prev Med Rep Date: 2019-10-25